Prosight Management, LP - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 86 filers reported holding UROGEN PHARMA LTD in Q2 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2020$2,608,000
-64.1%
146,179
-32.8%
1.22%
-61.8%
Q4 2019$7,264,000
-6.3%
217,686
-33.1%
3.19%
-25.9%
Q3 2019$7,754,000
-17.3%
325,385
+24.7%
4.30%
-9.0%
Q2 2019$9,378,000
+60.8%
260,928
+65.3%
4.73%
+85.3%
Q1 2019$5,831,000157,8622.55%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders